化合物LM11A-31 dihydrochloride T11861
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 1243259-19-9 | ¥11,200.00 | 询底价 |
2 mg | 1243259-19-9 | ¥571.00 | 询底价 |
50 mg | 1243259-19-9 | ¥3,760.00 | 询底价 |
10 mg | 1243259-19-9 | ¥1,220.00 | 询底价 |
200 mg | 1243259-19-9 | ¥7,580.00 | 询底价 |
25 mg | 1243259-19-9 | ¥2,550.00 | 询底价 |
100 mg | 1243259-19-9 | ¥5,390.00 | 询底价 |
5 mg | 1243259-19-9 | ¥897.00 | 询底价 |
1 mg | 1243259-19-9 | ¥397.00 | 询底价 |
Product Introduction
Bioactivity
英文名: LM11A-31 dihydrochloride
描述: LM11A-31 dihydrochloride 是一种具有高血脑屏障通透性的氨基酸衍生物,能阻断 p75 介导的细胞死亡。它是一种 p75NTR(神经营养蛋白受体 p75) 非肽调节剂,是口服有效的 proNGF 拮抗剂。它可以逆转中晚期的阿尔茨海默氏病小鼠模型中的胆碱能神经突营养不良。
体内活性: LM11A-31 (orally; 50 or 75 mg/kg) administered for 3 months starting at 6-8 months of age prevents and/or reverses atrophy of basal forebrain cholinergic neurites and cortical dystrophic neurites in mid-stage male APPL/S mice[2].?LM11A-31 (oral gavage;?50 mg kg/day for 4 weeks) significantly mitigates proNGF accumulation and preserves BRB integrity[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: H2O : 125 mg/mL (395.23 mM)
关键字: cholinergic | proNGF | Inhibitor | inhibit | LM11A-31 | growth | dystrophy | disease | p75 | Neurotensin Receptor | LM-11A-31 dihydrochloride | nerve | neurite | receptor | barrier | neurotrophin | factor | Ligand | LM11A 31 dihydrochloride | blood-brain | LM11A31 dihydrochloride | Alzheimer's | p75NTR | LM11A-31 Dihydrochloride
相关库: Drug Repurposing Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | CNS-Penetrant Compound Library | Inhibitor Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物LM11A-31 dihydrochloride T11861信息由TargetMol中国为您提供,如您想了解更多关于化合物LM11A-31 dihydrochloride T11861报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途